Annovis Bio, Inc. (ANVS) Misses Q3 EPS by 6c
Annovis Bio, Inc. (NYSE: ANVS) reported Q3 EPS of ($0.37), $0.06 worse than the analyst estimate of ($0.31).
For earnings history and earnings-related data on Annovis Bio, Inc. (ANVS) click here.
Annovis Bio, Inc. (NYSE: ANVS) reported Q3 EPS of ($0.37), $0.06 worse than the analyst estimate of ($0.31).
For earnings history and earnings-related data on Annovis Bio, Inc. (ANVS) click here.